Search Results
Search results for "Benjamin Franklin Medal"
Results found for "Benjamin Franklin Medal"
- OMass Therapeutics's founder, Carol Robinson, has been awarded the prestigious Louis-Jeantet ...
the prestigious Louis-Jeantet Prize for Medicine 2022 by the Louis-Jeantet Foundation and the 2022 Benjamin Franklin Medal in Chemistry from The Franklin Institute "Huge congratulations to our founder, Carol the prestigious Louis-Jeantet Prize for Medicine 2022 by the Louis-Jeantet Foundation and the 2022 Benjamin Franklin Medal in Chemistry from The Franklin Institute yesterday for contributions to the field of
- Ben Clements on Rescuing Opioids with GPCR Modulators
And Benjamin Clements is on a mission to fix it. In this powerful episode of the Dr.
- 📰 GPCR Weekly Buzz: Exciting Schedule Shifts for Principles of Pharmacology I & II | August 12-18, 2024
This week's highlight includes congrats to: Madison Walker , Benjamin Myers , et al., for their research
- Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal
That’s exactly what Terry’s Corner was built to do: bring four decades of frontline discovery insight Antibodies, Bias, and the Expanding Modality Landscape Antibody therapeutics are now entering spaces
- Coincident Regulation of PLCβ Signaling by Gq-Coupled and μOpioid Receptors Opposes Opioid- Mediated
The current frontline approach for pain-management is the use of opioid analgesics.
- 🎄 Have Yourself a Merry Little GPCRmas! ❄ Dec 9 - 15, 2024
week filled with prestigious events, including receiving the British Pharmacological Society Vane Medal
- A central alarm system that gates multi-sensory innate threat cues to the amygdala
findings suggest that parallel pathways independently relay innate threat signals from different sensory modalities about whether and how multi-sensory innate threat cues are integrated and conveyed from each sensory modality lateral parabrachial nucleus in the brainstem respond to multi-sensory threat cues from various sensory modalities
- Why GPCR Biologic Drugs Stabilize Active States Small Molecules Struggle to Reach
observation cleanly, and it has practical consequences for how programs at peptide receptors approach modality modulation deserves earlier consideration than it sometimes receives at these targets, and that biologic modalities
- 📰 GPCR Weekly News, December 4 to 10, 2023
disease, including first that uses CRISPR Pier Vincenzo Piazza, CEO of AELIS FARMA, Honored with Merit Medal
- 📰 GPCR Weekly News, October 30 to November 4, 2023
06954522 into a Phase 1 Trial Andrew Hopkins Inducted into RSC BMCS Hall of Fame and Receives Associated Medal
- Sweet taste receptor agonists attenuate macrophage IL‐1β expression and eosinophilic inflammation...
macrophage IL‐1β overproduction, thereby suggesting autophagy regulation as a potential therapeutic modality
- Orion Announces The Rapid Lead Optimization Of Ob-004 - A Ccr2 Antagonist
company unlocking the therapeutic potential of G Protein-Coupled Receptors (GPCRs) with a novel drug modality
- Identification of A2BAR as a potential target in colorectal cancer using novel fluorescent GPCR...
fluorescent ligands were effective at monitoring real-time A2BAR receptor labeling using live-imaging modalities
- GPCR Drug Discovery Summit 2026: What to Expect in Boston — and How to Register
pipelines, and a growing number of programs moving into the clinic are redefining what's possible across modalities
- Conjugation Strategies for Probe Development
(5) Meldal, M.; Tornøe, C. W. Cu-Catalyzed Azide−Alkyne Cycloaddition. Chem.
- Chemical Drug Matter : Rethinking the Molecules We Choose to Develop In Drug Discovery
Kenakin highlights how hybrid molecules — combining two pharmacophores into one scaffold — enable dual-modality
- 📰 GPCR Weekly News, August 7 to 13, 2023
GPCR Symposium on 'GPCRs as Therapeutic Modalities'. Want to share your project in a casual way?
- 📰 GPCR Weekly News, March 4 to 10, 2024
with selective and nonselective antagonists studied by NMR spectroscopy Up-regulation of GPR139 in the medial
- 📰 GPCR Weekly News, July 17 to July 23, 2023
GPCR Symposium on GPCRs as Therapeutic Modalities on September 22nd.
- 📰 GPCR Weekly News, August 21 to 27, 2023
GPCR Symposium on 'GPCRs as Therapeutic Modalities'.
- 📰 GPCR Weekly News, August 14 to 20, 2023
GPCR Symposium on 'GPCRs as Therapeutic Modalities'.
- 📰 GPCR Weekly News, July 24 to July 30, 2023
GPCR Symposium on GPCRs as Therapeutic Modalities is on September 22nd.
- Advantages of Fluorescent Probes in GPCR Assays
provide real-time data on receptor activation, ligand binding and downstream signaling using live-imaging modalities
- 📰 GPCR Weekly News, September 18 to 24, 2023
GPCR Symposium about 'GPCRs as Therapeutic Modalities' rocked it!
- 📰 GPCR Weekly News, September 11 to 17, 2023
GPCR Symposium on 'GPCRs as Therapeutic Modalities' with Richa Tyagi, Dr. Terry Kenakin, Dr.
- 📰 GPCR Weekly News, September 4 to 10, 2023
GPCR Symposium on ''GPCRs as Therapeutic Modalities' Share your project with a 1-minute abstract video
- 📰 GPCR Weekly News, August 28 to September 3, 2023
GPCR Symposium on 'GPCRs as Therapeutic Modalities' Showcase your project with a 1-minute abstract video
- 📰 GPCR Weekly News, July 31 to August 6, 2023
GPCR Symposium on 'GPCRs as Therapeutic Modalities' is set for September 22nd.
- Chemokine receptor-targeted drug discovery: progress and challenges
Overall, the future potential lies in using different therapeutic modalities to modulate the stromal
- GPCR Updates: Celebrating Breakthroughs, New Course Launches Soon, and Exclusive Discounts! | Aug 26 - Sep 1, 2024
Treasures Edelris Announces Research Services Agreement with Pfizer on Targeted Protein Degradation Modalities










